These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 14704683

  • 1. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
    Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN, Grecco HE, Jares-Erijman EA, Jovin TM.
    Nat Biotechnol; 2004 Feb; 22(2):198-203. PubMed ID: 14704683
    [Abstract] [Full Text] [Related]

  • 2. Enlightened receptor dynamics.
    Gur G, Yarden Y.
    Nat Biotechnol; 2004 Feb; 22(2):169-70. PubMed ID: 14755288
    [No Abstract] [Full Text] [Related]

  • 3. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane.
    Dinneen JL, Ceresa BP.
    Exp Cell Res; 2004 Apr 01; 294(2):509-22. PubMed ID: 15023538
    [Abstract] [Full Text] [Related]

  • 4. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
    Friedländer E, Arndt-Jovin DJ, Nagy P, Jovin TM, Szöllosi J, Vereb G.
    Cytometry A; 2005 Oct 01; 67(2):161-71. PubMed ID: 16163699
    [Abstract] [Full Text] [Related]

  • 5. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.
    Fuller SJ, Sivarajah K, Sugden PH.
    J Mol Cell Cardiol; 2008 May 01; 44(5):831-54. PubMed ID: 18430438
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
    Wingens M, Jacobs-Oomen S, van der Woning SP, Stortelers C, van Zoelen EJ.
    Biochemistry; 2006 Apr 11; 45(14):4703-10. PubMed ID: 16584205
    [Abstract] [Full Text] [Related]

  • 7. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
    Tao RH, Maruyama IN.
    J Cell Sci; 2008 Oct 01; 121(Pt 19):3207-17. PubMed ID: 18782861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
    van de Poll ML, van Rotterdam W, Gadellaa MM, Jacobs-Oomen S, van Zoelen EJ.
    Exp Cell Res; 2005 Apr 01; 304(2):630-41. PubMed ID: 15748906
    [Abstract] [Full Text] [Related]

  • 10. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
    Scheving LA, Zhang L, Stevenson MC, Kwak ES, Russell WE.
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul 01; 291(1):G16-25. PubMed ID: 16769812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons.
    Iwakura Y, Piao YS, Mizuno M, Takei N, Kakita A, Takahashi H, Nawa H.
    J Neurochem; 2005 May 01; 93(4):974-83. PubMed ID: 15857400
    [Abstract] [Full Text] [Related]

  • 13. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots.
    Kawashima N, Nakayama K, Itoh K, Itoh T, Ishikawa M, Biju V.
    Chemistry; 2010 Jan 25; 16(4):1186-92. PubMed ID: 20024999
    [Abstract] [Full Text] [Related]

  • 14. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane.
    Offterdinger M, Bastiaens PI.
    Traffic; 2008 Jan 25; 9(1):147-55. PubMed ID: 17956594
    [Abstract] [Full Text] [Related]

  • 15. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R.
    Biochem Biophys Res Commun; 2004 Jun 18; 319(1):1-11. PubMed ID: 15158434
    [Abstract] [Full Text] [Related]

  • 16. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
    Sweeney C, Carraway KL.
    Oncogene; 2000 Nov 20; 19(49):5568-73. PubMed ID: 11114736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis.
    Stonecypher MS, Chaudhury AR, Byer SJ, Carroll SL.
    J Neuropathol Exp Neurol; 2006 Feb 20; 65(2):162-75. PubMed ID: 16462207
    [Abstract] [Full Text] [Related]

  • 19. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L, Xiang B, Muthuswamy SK.
    Cancer Res; 2006 May 15; 66(10):5201-8. PubMed ID: 16707444
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.